Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC9A7P1 is a processed pseudogene corresponding to the functional gene SLC9A7 (sodium/hydrogen exchanger 7, NHE7), which is involved in intracellular pH regulation and ion exchange in the Golgi apparatus[3][8]. However, SLC9A7P1 itself is a non-coding genomic sequence and does not produce a functional protein. It is not a receptor, transporter, drug target, or associated with any biological activity, disease, or therapy. The confusion may arise because the functional SLC9A7 is an established sodium/proton antiporter, but the "pseudogene 1" variant (SLC9A7P1) lacks coding potential and therapeutic relevance[3][8]. If information regarding actual therapeutic targets or active sodium/proton exchangers is needed, refer to SLC9A7 or other members of the solute carrier family 9 (NHE) gene family[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 9 member 7 pseudogene 1 (SLC9A7P1).